Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens

Cell

Volumn 124, Issue 4, 2006, Pages 767-782

  Finlay, B Brett ^a   McFadden, Grant ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CHEMOKINE; CYTOKINE; IMMUNOMODULATING AGENT; TOLL LIKE RECEPTOR; VIRUS ANTIGEN; VIRUS PROTEIN;

ACUTE DISEASE; ADAPTATION; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL DEATH; CELL SURFACE; CELLULAR IMMUNITY; CHRONIC DISEASE; CLEARANCE; COMPLEMENT INHIBITION; CYTOKINE PRODUCTION; EVOLUTION; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; MICROBIAL IMMUNITY; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; SECRETION; VERTEBRATE; VIRION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS VIRULENCE;

BACTERIA (MICROORGANISMS); VERTEBRATA;

EID: 32944462309     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.01.034     Document Type: Review

References (157)

1. A.L. Ackerman, and P. Cresswell Cellular mechanisms governing cross-presentation of exogenous antigens Nat. Immunol. 5 2004 678 684
2. B. Ahr, V. Robert-Hebmann, C. Devaux, and M. Biard-Piechaczyk Apoptosis of uninfected cells induced by HIV envelope glycoproteins Retrovirology 1 2004 1 12
3. A. Alcami Viral mimicry of cytokines, chemokines and their receptors Nat. Rev. Immunol. 3 2003 36 50
4. A.P. Ambagala, J.C. Solheim, and S. Srikumaran Viral inteference with MHC class I antigen presentation pathway: the battle continues Vet. Immunol. Immunopathol. 107 2005 1 15
5. D.M. Andrews, C.E. Andoniou, A.A. Scalzo, S.L.H. van Dommelen, M.E. Wallace, M.J. Smyth, and M.A. Degli-Esposti Cross-talk between dendritic cells and natural killer cells in viral infection Mol. Immunol. 42 2005 547 555
6. M.W. Bader, S. Sanowar, M.E. Daley, A.R. Schneider, U. Cho, W. Xu, R.E. Klevit, H. Le Moual, and S.I. Miller Recognition of antimicrobial peptides by a bacterial sensor kinase Cell 122 2005 461 472
7. G. Badr, G. Borhis, D. Treton, C. Moog, O. Garraud, and Y. Richard HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL) 20, and CCL21 J. Immunol. 175 2005 302 310
8. E.M. Bautista, G.S. Ferman, D. Gregg, M.C. Brum, M.J. Grubman, and W.T. Golde Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus J. Virol. 79 2005 4838 4847
9. M.P. Bergman, A. Engering, H.H. Smits, S.J. van Vliet, A.A. van Bodegraven, H.P. Wirth, M.L. Kapsenberg, C.M. Vandenbroucke-Grauls, Y. van Kooyk, and B.J. Appelmelk Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN J. Exp. Med. 200 2004 979 990
10. P.D. Bieniasz Intrinsic immunity: a front-line defense against viral attack Nat. Immunol. 5 2004 1109 1115
11. A.M. Blom Strategies developed by bacteria and virus for protection from the human complement system Scand. J. Clin. Lab. Invest. 64 2004 479 496
12. K.W. Boehme, and T. Compton Innate sensing of viruses by toll-like receptors J. Virol. 78 2004 7867 7873
13. I.G. Boneca The role of peptidoglycan in pathogenesis Curr. Opin. Microbiol. 8 2005 46 53
14. C.A. Bonjardim Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses-and viruses counteract IFN action Microbes Infect. 7 2005 569 578
15. J.M. Boomker, L.F.M.H.L. de Leij, T.H. The, and M.C. Harmsen Viral chemokine modulatory proteins: tools and targets Cytokine Growth Factor Rev. 16 2005 91 103
16. I.C. Boulton, and S.D. Gray-Owen Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes Nat. Immunol. 3 2002 229 236
17. D.G. Bowen, and C.M. Walker Adaptive immune responses in acute and chronic hepatitis C virus infection Nature 436 2005 946 952
18. A.G. Bowie, and I.R. Haga The role of Toll-like receptors in the host response to viruses Mol. Immunol. 42 2005 859 867
19. A.G. Bowie, J. Zhan, and W.L. Marshall Viral appropriation of apoptotic and NF-kappaB signaling pathways J. Cell. Biochem. 91 2004 1099 1108
20. P. Boya, A.L. Pauleau, D. Poncet, R.A. Gonzalez-Polo, N. Zamzami, and G. Kroemer Viral proteins targeting mitochondria: controlling cell death Biochim. Biophys. Acta 1659 2004 178 189
21. A. Breiman, N. Grandvaux, R. Lin, C. Ottone, S. Akira, M. Yoneyama, T. Fujita, J. Hiscott, and E.F. Meurs Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon J. Virol. 79 2005 3969 3978
22. D. Cabanes, O. Dussurget, P. Dehoux, and P. Cossart Auto, a surface associated autolysin of Listeria monocytogenes required for entry into eukaryotic cells and virulence Mol. Microbiol. 51 2004 1601 1614
23. C.M. Cameron, J.W. Barrett, L. Liu, A.R. Lucas, and G. McFadden Myxoma virus M141R expresses a viral CD200 (vOX-2) that is responsible for down-regulation of macrophage and T-cell activation in vivo J. Virol. 79 2005 6052 6067
24. R. Cantin, S. Methot, and M.J. Tremblay Plunder and stowaways: incorporation of cellular proteins by enveloped viruses J. Virol. 79 2005 6577 6587
25. J. Celli, and B.B. Finlay Bacterial avoidance of phagocytosis Trends Microbiol. 10 2002 232 237
26. D. Chakravortty, and M. Hensel Inducible nitric oxide synthase and control of intracellular bacterial pathogens Microbes Infect. 5 2003 621 627
27. Y.J. Chang, M. Jiang, J.M. Lubinski, R.D. King, and H.M. Friedman Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains Vaccine 23 2005 4658 4665
28. B. Chen, E.M. Vogan, H. Gong, J.J. Skehel, D.C. Wiley, and S.C. Harrison Structure of an unliganded simian immunodeficiency virus gp120 core Nature 433 2005 834 841
29. T.C. Cheung, I.R. Humphreys, K.G. Potter, P.S. Norris, H.M. Shumway, B.R. Tran, G. Patterson, R. Jean-Jacques, M. Yoon, and P.G. Spear Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway Proc. Natl. Acad. Sci. USA 102 2005 13218 13223
30. P.J. Christie, K. Atmakuri, V. Krishnamoorthy, S. Jakubowski, and E. Cascales Biogenesis, architecture, and function of bacterial type iv secretion systems Annu. Rev. Microbiol. 59 2005 451 485
31. B.K. Coombes, Y. Valdez, and B.B. Finlay Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses Curr. Biol. 14 2004 R856 R867
32. J.P. Couty, and M.C. Gershengorn G-protein-coupled receptors encoded by human herpesviruses Trends Pharmacol. Sci. 26 2005 405 411
33. D.M. D'Agostino, P. Bernardi, L. Chieco-Bianchi, and V. Ciminale Mitochondria as functional targets of proteins coded by human tumor viruses Adv. Cancer Res. 94 2005 87 142
34. R.P. Darveau, T.T. Pham, K. Lemley, R.A. Reife, B.W. Bainbridge, S.R. Coats, W.N. Howald, S.S. Way, and A.M. Hajjar Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4 Infect. Immun. 72 2004 5041 5051
35. C.A. Derdeyn, and G. Silvestri Viral and host factors in the pathogenesis of HIV infection Curr. Opin. Immunol. 17 2005 366 373
36. V. Deretic Autophagy in innate and adaptive immunity Trends Immunol. 26 2005 523 528
37. G. DiPerna, J. Stacks, A.G. Bowie, A. Boyd, G. Kowal, Z. Zhang, S. Arvikar, E. Latz, K.A. Fitzgerald, and W.L. Marshall Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB and IRF3 signaling by toll-like receptors J. Biol. Chem. 279 2004 36570 36578
38. B.G. Dorner, H.R. Smith, A.R. French, S. Kim, J. Poursine-Laurent, D.L. Beckman, J.T. Pingel, R.A. Kroczek, and W.M. Yokoyama Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection J. Immunol. 172 2004 3119 3131
39. K.H. Edelmann, S. Richardson-Burns, L. Alexopoulou, K.L. Tyler, R.A. Flavell, and M.B. Oldstone Does Toll-like receptor 3 play a biological role in virus infections? Virology 322 2004 231 238
40. S.F. Elena, and R. Sanjuan Adaptive value of high mutation rates of RNA viruses: separating causes from consequences J. Virol. 79 2005 11555 11558
41. R.K. Ernst, T. Guina, and S.I. Miller Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity Microbes Infect. 3 2001 1327 1334
42. T. Fan, H. Lu, H. Hu, L. Shi, G.A. McClarty, D.M. Nance, A.H. Greenberg, and G. Zhong Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation J. Exp. Med. 187 1998 487 496
43. A.S. Fauci The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research Nat. Immunol. 6 2005 743 747
44. V. Fensterl, D. Grotheer, I. Berk, S. Schlemminger, A. Vallbracht, and A. Dotzauer Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon J. Virol. 79 2005 10968 10977
45. R.W. Finberg, and E.A. Kurt-Jones Viruses and Toll-like receptors Microbes Infect. 6 2004 1356 1360
46. B.B. Finlay, and S. Falkow Common themes in microbial pathogenicity revisited Microbiol. Mol. Biol. Rev. 61 1997 136 169
47. B.B. Finlay, and R.E. Hancock Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2 2004 497 504
48. E. Flano, B. Kayhan, D.L. Woodland, and M.A. Blackman Infection of dendritic cells by a {gamma}2-herpesvirus induces functional modulation J. Immunol. 175 2005 3225 3234
49. M. Foster-Cuevas, G.J. Wright, M.J. Puklavec, M.H. Brown, and A.N. Barclay Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor J. Virol. 78 2004 7667 7676
50. E. Foy, K. Li, R. Sumpter Jr., Y.M. Loo, C.L. Johnson, C. Wang, P.M. Fish, M. Yoneyama, T. Fujita, S.M. Lemon, and M. Gale Jr. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling Proc. Natl. Acad. Sci. USA 102 2005 2986 2991
51. S. Freigang, H.C. Probst, and M. van den Broek DC infection promotes antiviral CTL priming: the 'Winkelried' strategy Trends Immunol. 26 2005 13 18
52. A.R. French, J.T. Pingel, M. Wagner, I. Bubic, L. Yang, S. Kim, U. Koszinowski, S. Jonjic, and W.M. Yokoyama Escape of mutant double-stranded DNA virus from innate immune control Immunity 20 2004 747 756
53. E.C. Freundt, and M.J. Lenardo Interfering with interferons: Hepatitis C virus counters innate immunity Proc. Natl. Acad. Sci. USA 102 2005 17539 17540
54. B. Gebert, W. Fischer, E. Weiss, R. Hoffmann, and R. Haas Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation Science 301 2003 1099 1102
55. S.E. Girardin, I.G. Boneca, L.A. Carneiro, A. Antignac, M. Jehanno, J. Viala, K. Tedin, M.K. Taha, A. Labigne, and U. Zahringer Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan Science 300 2003 1584 1587
56. S.E. Girardin, L.H. Travassos, M. Herve, D. Blanot, I.G. Boneca, D.J. Philpott, P.J. Sansonetti, and D. Mengin-Lecreulx Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2 J. Biol. Chem. 278 2003 41702 41708
57. M.I. Gomez, A. Lee, B. Reddy, A. Muir, G. Soong, A. Pitt, A. Cheung, and A. Prince Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 Nat. Med. 10 2004 842 848
58. M.L. Gougeon To kill or be killed: how HIV exhausts the immune system Cell Death Differ. 12 Suppl. 1 2005 845 854
59. D.G. Guiney The role of host cell death in Salmonella infections Curr. Top. Microbiol. Immunol. 289 2005 131 150
60. J.A. Hamerman, K. Ogasawara, and L.L. Lanier NK cells in innate immunity Curr. Opin. Immunol. 17 2005 29 35
61. R.E. Hancock Cationic peptides: effectors in innate immunity and novel antimicrobials Lancet Infect. Dis. 1 2001 156 164
62. T.M. Handel, Z. Johnson, S.E. Crown, E.K. Lau, and A.E. Proudfoot Regulation of protein function by glycosaminoglycans-as exemplified by chemokines Annu. Rev. Biochem. 74 2005 385 410
63. M.T. Harte, I.R. Haga, G. Maloney, P. Gray, P.C. Reading, N.W. Bartlett, G.L. Smith, A. Bowie, and L.A.J. O'Neill The poxvirus protein A52R targets toll-like receptor signaling complexes to suppress host defense J. Exp. Med. 197 2003 343 351
64. N.R. Hegde, and D.C. Johnson A seek-and-hide game between Cd1-restricted T cells and herpesviruses J. Clin. Invest. 115 2005 1146 1149
65. H. Hengel, U.H. Koszinowski, and K.K. Conzelmann Viruses know it all: new insights into IFN networks Trends Immunol. 26 2005 396 401
66. M.R. Hilleman Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections Proc. Natl. Acad. Sci. USA 101 Suppl. 2 2004 14560 14566
67. G.H. Holm, and D. Gabuzda Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions J. Virol. 79 2005 6299 6311
68. M.W. Hornef, M.J. Wick, M. Rhen, and S. Normark Bacterial strategies for overcoming host innate and adaptive immune responses Nat. Immunol. 3 2002 1033 1040
69. C. Inohara, C. McDonald, and G. Nunez NOD-LRR proteins: role in host-microbial interactions and inflammatory disease Annu. Rev. Biochem. 74 2005 355 383
70. P. Jha, and G.J. Kotwal Vaccinia complement control protein: multi-functional protein and a potential wonder drug J. Biosci. 28 2003 265 271
71. Z. Johnson, M. Schwarz, C.A. Power, T.N. Wells, and A.E. Proudfoot Multi-faceted strategies to combat disease by interference with the chemokine system Trends Immunol. 26 2005 268 274
72. I. Jutras, and M. Desjardins Phagocytosis: at the crossroads of innate and adaptive immunity Annu. Rev. Cell Dev. Biol. 21 2005 511 527
73. C.M. Kahler, and D.S. Stephens Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin) Crit. Rev. Microbiol. 24 1998 281 334
74. H. Kato, S. Sato, M. Yoneyama, M. Yamamoto, S. Uematsu, K. Matsui, T. Tsujimura, K. Takeda, T. Fujita, O. Takeuchi, and S. Akira Cell type-specific involvement of RIG-I in antiviral response Immunity 23 2005 19 28
75. T. Kawai, and S. Akira Pathogen recognition with Toll-like receptors Curr. Opin. Immunol. 17 2005 338 344
76. K. Kawasaki, R.K. Ernst, and S.I. Miller 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4 J. Biol. Chem. 279 2004 20044 20048
77. D.W. Kim, G. Lenzen, A.L. Page, P. Legrain, P.J. Sansonetti, and C. Parsot The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes Proc. Natl. Acad. Sci. USA 102 2005 14046 14051
78. P. Klenerman, and A. Hill T cells and viral persistence: lessons from diverse infections Nat. Immunol. 6 2005 873 879
79. L.A. Knodler, B.B. Finlay, and O. Steele-Mortimer The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt J. Biol. Chem. 280 2005 9058 9064
80. M. Kotb, A. Norrby-Teglund, A. McGeer, H. El-Sherbini, M.T. Dorak, A. Khurshid, K. Green, J. Peeples, J. Wade, and G. Thomson An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections Nat. Med. 8 2002 1398 1404
81. L.L. Lanier NK cell recognition Annu. Rev. Immunol. 23 2005 225 274
82. E.K. Lau, S. Allen, A.R. Hsu, and T.M. Handel Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins Adv. Protein Chem. 68 2004 351 391
83. L.L. Lenz, S. Mohammadi, A. Geissler, and D.A. Portnoy SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis Proc. Natl. Acad. Sci. USA 100 2003 12432 12437
84. N.L. Letvin Progress toward an HIV vaccine Annu. Rev. Med. 56 2005 213 223
85. B. Levine Eating oneself and uninvited guests: autophagy-related pathways in cellular defense Cell 120 2005 159 162
86. K. Li, E. Foy, J.C. Ferreon, M. Nakamura, A.C. Ferreon, M. Ikeda, S.C. Ray, M. Gale Jr., and S.M. Lemon Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF Proc. Natl. Acad. Sci. USA 102 2005 2992 2997
87. X.D. Li, L. Sun, R.B. Seth, G. Pineda, and Z.J. Chen From the Cover: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity Proc. Natl. Acad. Sci. USA 102 2005 17717 17722
88. A.M. Likos, S.A. Sammons, V.A. Olson, A.M. Frace, Y. Li, M. Olsen-Rasmussen, W. Davidson, R. Galloway, M.L. Khristova, and M.G. Reynolds A tale of two clades: monkeypox viruses J. Gen. Virol. 86 2005 2661 2672
89. B.N. Lilley, and H.L. Ploegh Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond Immunol. Rev. 207 2005 126 144
90. Y.J. Liu IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors Annu. Rev. Immunol. 23 2005 275 306
91. M.B. Lodoen, and L.L. Lanier Viral modulation of NK cell immunity Nat. Rev. Microbiol. 3 2005 59 69
92. A. Lucas, and G. McFadden Secreted immunomodulatory viral proteins as novel biotherapeutics J. Immunol. 173 2004 4765 4774
93. L. Lybarger, X. Wang, M. Harris, and T.H. Hansen Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways Curr. Opin. Immunol. 17 2005 71 78
94. J.C. Madden, N. Ruiz, and M. Caparon Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in gram-positive bacteria Cell 104 2001 143 152
95. B. Majumder, M.L. Janket, E.A. Schafer, K. Schaubert, X.L. Huang, J. Kan-Mitchell, C.R. Rinaldo Jr., and V. Ayyavoo Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape J. Virol. 79 2005 7990 8003
96. L. Mark, W.H. Lee, O.B. Spiller, D. Proctor, D.J. Blackbourn, B.O. Villoutreix, and A.M. Blom The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system J. Biol. Chem. 279 2004 45093 45101
97. D.M. Monack, D. Hersh, N. Ghori, D. Bouley, A. Zychlinsky, and S. Falkow Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model J. Exp. Med. 192 2000 249 258
98. D.M. Morens, G.K. Folkers, and A.S. Fauci The challenge of emerging and re-emerging infectious diseases Nature 430 2004 242 249
99. B.P. Morgan, K.J. Marchbank, M.P. Longhi, C.L. Harris, and A.M. Gallimore Complement: central to innate immunity and bridging to adaptive responses Immunol. Lett. 97 2005 171 179
100. L.J. Mota, and G.R. Cornelis The bacterial injection kit: type III secretion systems Ann. Med. 37 2005 234 249
101. P.N. Moynagh TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway Trends Immunol. 26 2005 469 476
102. J. Mullick, J. Bernet, Y. Panse, S. Hallihosur, A.K. Singh, and A. Sahu Identification of complement regulatory domains in vaccinia virus complement control protein J. Virol. 79 2005 12382 12393
103. J. Mullick, A.K. Singh, Y. Panse, V. Yadav, J. Bernet, and A. Sahu Identification of functional domains in kaposica, the complement control protein homolog of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) J. Virol. 79 2005 5850 5856
104. H. Nagai, J.C. Kagan, X. Zhu, R.A. Kahn, and C.R. Roy A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes Science 295 2002 679 682
105. W.W. Navarre, and A. Zychlinsky Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies Cell. Microbiol. 2 2000 265 273
106. L. Navarro, N.M. Alto, and J.E. Dixon Functions of the Yersinia effector proteins in inhibiting host immune responses Curr. Opin. Microbiol. 8 2005 21 27
107. M.G. Netea, J.W. Van der Meer, and B.J. Kullberg Toll-like receptors as an escape mechanism from the host defense Trends Microbiol. 12 2004 484 488
108. J. Nicholas Human gammaherpesvirus cytokines and chemokine receptors J. Interferon Cytokine Res. 25 2005 373 383
109. C. Paludan, D. Schmid, M. Landthaler, M. Vockerodt, D. Kube, T. Tuschl, and C. Munz Endogenous MHC class II processing of a viral nuclear antigen after autophagy Science 307 2005 593 596
110. J.M. Park, F.R. Greten, Z.W. Li, and M. Karin Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition Science 297 2002 2048 2051
111. C. Parra-Lopez, M.T. Baer, and E.A. Groisman Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium EMBO J. 12 1993 4053 4062
112. J.-L. Perfetti, M. Castedo, T. Roumier, K. Andreau, R. Nardacci, M. Placentini, and G. Kroemer Mechanisms of apoptosis induction by the HIV-1 envelope Cell Death Differ. 12 2005 916 923
113. C. Petrovas, Y.M. Mueller, and P.D. Katsikis Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy Cell Death Differ. 12 Suppl. 1 2005 859 870
114. D.J. Philpott, and S.E. Girardin The role of Toll-like receptors and Nod proteins in bacterial infection Mol. Immunol. 41 2004 1099 1108
115. G. Pollara, A. Kwan, P.J. Newton, M.E. Handley, B.M. Chain, and D.R. Katz Dendritic cells in viral pathogenesis: protective or defective Int. J. Exp. Pathol. 86 2005 187 204
116. D.A. Portnoy Manipulation of innate immunity by bacterial pathogens Curr. Opin. Immunol. 17 2005 25 28
117. S. Rajagopalan, and E.O. Long Viral evasion of NK-cell activation Trends Immunol. 26 2005 403 405
118. G.J. Renukaradhya, T.J. Webb, M.A. Khan, Y.L. Lin, W. Du, J. Gervay-Hague, and R.R. Brutkiewicz Virus-induced inhibition of CD1d1-mediated antigen presentation: Reciprocal regulation by p38 and ERK J. Immunol. 175 2005 4301 4308
119. C.R. Rinaldo Jr., and P. Piazza Virus infection of dendritic cells: portal for host invasion and host defense Trends Microbiol. 12 2004 337 345
120. S.H. Rooijakkers, M. Ruyken, A. Roos, M.R. Daha, J.S. Presanis, R.B. Sim, W.J. van Wamel, K.P. van Kessel, and J.A. van Strijp Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases Nat. Immunol. 6 2005 920 927
121. C.M. Rosenberger, and B.B. Finlay Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens Nat. Rev. Mol. Cell Biol. 4 2003 385 396
122. C.M. Rosenberger, R.L. Gallo, and B.B. Finlay Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication Proc. Natl. Acad. Sci. USA 101 2004 2422 2427
123. M.M. Rosenkilde Virus-encoded chemokine receptors - putative novel antiviral drug targets Neuropharmacology 48 2005 1 13
124. M. Rossi, and J.W. Young Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity J. Immunol. 175 2005 1373 1381
125. A. Rot, and U.H. von Andrian Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells Annu. Rev. Immunol. 22 2004 891 928
126. D.G. Russell Mycobacterium tuberculosis: here today, and here tomorrow Nat. Rev. Mol. Cell Biol. 2 2001 569 577
127. D.J. Sanchez, J.E. Gumperz, and D. Ganem Regulation of CD1d expression and function by a herpesvirus infection J. Clin. Invest. 115 2005 1369 1378
128. P.J. Sansonetti War and peace at mucosal surfaces Nat. Rev. Immunol. 4 2004 953 964
129. C. Schauber-Plewa, A. Simmons, M.J. Tuerk, C.D. Pacheco, and G. Veres Complement regulatory proteins are incorporated into lentiviral vectors and protect particles against complement inactivation Gene Ther. 12 2005 238 245
130. M. Schroder, and A.G. Bowie TLR3 in antiviral immunity: key player or bystander? Trends Immunol. 26 2005 462 468
131. B.T. Seet, J.B. Johnston, C.R. Brunetti, J.W. Barrett, H. Everett, C. Cameron, J. Sypula, S.H. Nazarian, A. Lucas, and G. McFadden Poxviruses and immune evasion Annu. Rev. Immunol. 21 2003 377 423
132. R.B. Seth, L. Sun, C.K. Ea, and Z.J. Chen Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF3 Cell 122 2005 669 682
133. L.A. Shackelton, C.R. Parrish, U. Truyen, and E.C. Holmes High rate of viral evolution associated with the emergence of carnivore parvovirus Proc. Natl. Acad. Sci. USA 102 2005 379 384
134. A. Sing, D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, C.J. Kirschning, M. Aepfelbacher, and J. Heesemann Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression J. Exp. Med. 196 2002 1017 1024
135. A. Sing, D. Reithmeier-Rost, K. Granfors, J. Hill, A. Roggenkamp, and J. Heesemann A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence Proc. Natl. Acad. Sci. USA 102 2005 16049 16054
136. A. Sodhi, S. Mantaner, and J.S. Gutkind Viral hijacking of G-protein coupled-receptor signalling networks Nat. Rev. Mol. Cell Biol. 5 2004 998 1012
137. P.G. Spear Herpes simplex virus: receptors and ligands for cell entry Cell. Microbiol. 6 2004 401 410
138. J. Stack, I.R. Haga, M. Schroder, N.W. Bartlett, G. Maloney, P.C. Reading, K.A. Fitzgerald, G.L. Smith, and A.G. Bowie Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence J. Exp. Med. 201 2005 1007 1018
139. S.A. Stanley, S. Raghavan, W.W. Hwang, and J.S. Cox Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system Proc. Natl. Acad. Sci. USA 100 2003 13001 13006
140. R. Sumpter Jr., Y.M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S.M. Lemon, and M. Gale Jr. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I J. Virol. 79 2005 2689 2699
141. K. Tabeta, P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, and J. Goode Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection Proc. Natl. Acad. Sci. USA 101 2004 3516 3521
142. C.M. Tato, and C.A. Hunter Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection Infect. Immun. 70 2002 3311 3317
143. M.K. Tewari, G. Sinnathamby, D. Rajagopal, and L.C. Eisenlohr A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent Nat. Immunol. 6 2005 287 294
144. D.M. Underhill Toll-like receptors and microbes take aim at each other Curr. Opin. Immunol. 16 2004 483 487
145. B.A. Vallance, W. Deng, M. De Grado, C. Chan, K. Jacobson, and B.B. Finlay Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen citrobacter rodentium in infected mice Infect. Immun. 70 2002 6424 6435
146. A. Vazquez-Torres, Y. Xu, J. Jones-Carson, D.W. Holden, S.M. Lucia, M.C. Dinauer, P. Mastroeni, and F.C. Fang Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase Science 287 2000 1655 1658
147. G.I. Viboud, and J.B. Bliska YERSINIA OUTER PROTEINS: Role in modulation of host cell signaling responses and pathogenesis Annu. Rev. Microbiol. 59 2005 69 89
148. T. Walzer, L. Galibert, and T. De Smedt Poxvirus semaphorin A39R inhibits phagocytosis by dendritic cells and neutrophils Eur. J. Immunol. 35 2005 391 398
149. T. Wang, T. Town, L. Alexopoulou, J.F. Anderson, E. Fikrig, and R.A. Flavell Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis Nat. Med. 10 2004 1366 1373
150. T.H. Watts, and J.L. Gommerman The LIGHT and DARC sides of herpesvirus entry mediator Proc. Natl. Acad. Sci. USA 102 2005 13365 13366
151. L.M. Webb, and A. Alcami Virally encoded chemokine binding proteins Mini Rev. Med. Chem. 5 2005 833 848
152. F. Weber, G. Kochs, and O. Haller Inverse interference: how viruses fight the interferon system Viral Immunol. 17 2004 498 515
153. S.F. Wieland, and F.V. Chisari Stealth and cunning: hepatitis B and hepatitis C viruses J. Virol. 79 2005 9369 9380
154. L.-G. Xu, Y.-Y. Wang, K.-J. Han, L.-Y. Li, Z. Zhai, and H.-B. Shu VISA is an adapter rotein required for virus-triggered IFN-beta signaling Mol. Cell 19 2005 1 14
155. J.W. Yewdell, and S.M. Haeryfar Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design Annu. Rev. Immunol. 23 2005 651 682
156. W.M. Yokoyama Natural killer cell immune response Immunol. Res. 32 2005 317 325
157. M. Yoneyama, M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses Nat. Immunol. 5 2004 730 737